Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126703061 | 12670306 | 1 | I | 20160727 | 20160822 | 20160822 | PER | US-009507513-1607USA012384 | MERCK | 0.00 | M | Y | 77.11000 | KG | 20160822 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126703061 | 12670306 | 1 | PS | REMERON | MIRTAZAPINE | 1 | Oral | 7.5 MG, AT NIGHT | 20415 | 7.5 | MG | TABLET | QD | ||||||
126703061 | 12670306 | 2 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | UNK, QD | 0 | TABLET | QD | ||||||||
126703061 | 12670306 | 3 | C | PRINIVIL | LISINOPRIL | 1 | Oral | UNK, QD, STARTED FROM OVER 10 YEARS | 0 | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126703061 | 12670306 | 1 | Sleep disorder |
126703061 | 12670306 | 2 | Blood pressure abnormal |
126703061 | 12670306 | 3 | Blood pressure abnormal |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126703061 | 12670306 | Depression | |
126703061 | 12670306 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126703061 | 12670306 | 1 | 2014 | 0 |